New HampshireHB17962025-2026 Regular SessionHouse

allowing the use of psilocybin in approved clinical settings to treat qualified medical conditions.

Sponsored By: Michael I Moffett (Republican)

Introduced

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Michael I Moffett

    Republican • House

Cosponsors

  • Carol M McGuire

    Republican • House

  • David H. Watters

    Democratic • Senate

  • Henry R Giasson

    Republican • House

  • Howard Pearl

    Republican • Senate

  • Jennifer Mandelbaum

    Democratic • House

  • Matt R Sabourin dit Choini�re

    Republican • House

  • Terry W Roy

    Republican • House

  • Tom D Mannion

    Republican • House

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Minority Committee Report: Ought to Pass

    2/3/2026House
  2. Majority Committee Report: Inexpedient to Legislate 01/28/2026 (Vote 11-7; RC) HC 10 P. 91

    2/3/2026House
  3. Executive Session: 01/28/2026 02:30 pm GP 158

    1/21/2026House
  4. Public Hearing: 01/14/2026 02:00 pm GP 158

    1/8/2026House
  5. Introduced 01/07/2026 and referred to Health, Human Services and Elderly Affairs HJ 1 P. 36

    12/17/2025House

Bill Text

  • Introduced

    12/17/2025

Related Bills

Back to State Legislation